The UK's first safe drug consumption facility was due to open in October, but has been pushed back. A man and a woman were arrested after hundreds of thousands of pounds worth of the drug were found.

Additionally, your healthcare provider might order other thyroid tests in conjunction with the TPO antibody test, which could include thyroglobulin antibodies, thyroid-stimulating hormone (TSH), free ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...

Antibody-drug conjugates (ADCs) hold great promise as targeted cancer therapeutics. But their complex structure poses significant development and safety challenges for biopharma. In this GEN ...

Among them, 22 candidates have entered clinical trials, including 11 bispecific/multispecific antibodies and bispecific antibody-drug conjugates. Additionally, it has five drugs that are commercially ...

One thing that makes several of them stand out is that drug use from their recent or distant past is not a major issue, is overshadowed by other issues or is not currently raising a furor in an ...

SHANGHAI and BOSTON, Nov. 18, 2024 /PRNewswire/ -- VelaVigo Cayman Limited (VelaVigo), a biotech company focusing on discovery and development of multi-specific antibodies and antibody-drug conjugates ...

The grant focuses on a promising new prodrug, CTT2274, that targets Prostate-Specific Membrane Antigen (PSMA) on prostate cancer and is designed to release a toxic drug, MMAE, within the cell that ...

ACE1831 is also in a Phase 1 dose escalation study for non-Hodgkin's lymphoma (NHL). "Based on the observation of clinical benefits of CAR-T in autoimmune diseases, we hope to prove that ACE1831 can ...

has bought into the kind of drug that has emerged as a top threat to its dominant cancer immunotherapy ... In its statement, Merck said LM-299 has a “differentiated molecular design” than others in ...

The recent advancements in the TATX-112 program have led to the discovery of multiple antibodies that can infiltrate and eliminate TrkB-expressing cells in an in vitro surrogate Antibody Drug ...